Search results
EU regulators approve BeiGene's tislelizumab for lung cancer (NASDAQ:BGNE)
Seeking Alpha· 4 days agoEU regulators have approved BeiGene’s (NASDAQ:BGNE) tislelizumab for the treatment of three types of...
Gilead gives up on $4.9B antibody as solid tumor plan unravels
FierceBiotech· 2 days agoA $4.9 billion hole has appeared in Gilead’s pipeline. After years of setbacks, the big biotech dealt a final blow to its anti-CD47 monoclonal antibody magrolimab Thursday by removing the remaining ...
Real World Economics: Reflections on cancer and GDP’s limitations
Pioneer Press· 7 days agoTwelve years ago today my ENT called saying a pathologist confirmed I had a squamous cell carcinoma....
Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday? - Immutep (NASDAQ:IMMP)
Benzinga· 3 days agoImmutep releases preliminary results from TACTI-003 trial showing promising outcomes for first-line...
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoFusion (FUSN) is expected to provide updates regarding the developmental program of its lead...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 3 days agoThe NDA is supported by results from JUPITER-02, a randomized, double...
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Benzinga via Yahoo Finance· 3 days agoInc (NASDAQ:HOOK) received clearance from the FDA for its Investigational New Drug (IND) application...
Adlai Nortye (NASDAQ:ANL) Shares Gap Up to $12.40
ETF DAILY NEWS· 4 days agoAdlai Nortye Ltd. (NASDAQ:ANL – Get Free Report)’s share price gapped up before the market opened on Monday . The stock had previously closed at $12.40, but opened at $13.75. Adlai Nortye shares ...
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday? - HOOKIPA Pharma (NASDAQ:HOOK)
Benzinga· 3 days agoIn January, Roche terminated the collaboration and licensing agreement for HOOKIPA’s HB-700 program...
The Cancer Screenings Every Young Woman Should Get
AOL· 5 days agoYou were probably shocked when Catherine, Princess of Wales, announced that she had cancer. It’s true that cancer in young adults is very uncommon—only ...
